FTO-mediated demethylation of PRKCB mRNA activates NF-κB to trigger alveolar fibrin deposition in ARDS
4 affiliations
- 1Department of Critical Care Medicine, The Affiliated Hospital of Guizhou Medical University
- 2Department of Respiratory and Critical Care Medicine, Wuhan No. 1 Hospital
- 3Department of Anorectal Surgery, The Affiliated Hospital of Guizhou Medical University
- 4Houshan Township Health Center
Abstract
Background: Acute Respiratory Distress Syndrome (ARDS) is characterized by alveolar fibrin deposition, driven by dysregulated hypercoagulation and impaired fibrinolysis. Although alveolar epithelial type II (AEC II) cells contribute to this imbalance by overexpressing Tissue Factor (TF) and Plasminogen Activator Inhibitor-1 (PAI-1), the upstream regulatory mechanisms, particularly at the epitranscriptomic level, remain unclear. The potential role of the N6-methyladenosine (m ⁶ A) RNA demethylase FTO in ARDS pathogenesis is unexplored.
Methods: In this study, we employed lipopolysaccharide (LPS)-induced rat ARDS models and LPS-stimulated AEC II cells as primary experimental systems to investigate the underlying mechanisms. Multi-omics profiling, combining methylated RNA immunoprecipitation sequencing (MeRIP-seq) and RNA sequencing (RNA-seq), was performed. Gain and loss-of-function studies were conducted using lentiviral vectors both in vitro and in vivo . Mechanistic investigations involved MeRIP-qPCR, mRNA stability assays, co-immunoprecipitation (Co-IP), Western blot, immunofluorescence, and pharmacological modulation of the NF-κB pathway.
Results: Lungs from ARDS rats showed decreased global levels and increased FTO expression. Knockdown of FTO alleviated lung injury, reduced pulmonary edema, and suppressed the expression of TF and PAI-1, concomitant with inhibition of NF-κB signaling. Integrated multi-omics analysis identified Protein Kinase C Beta (PRKCB), a serine/threonine kinase known to regulate inflammatory signaling, as a key target of FTO. Mechanistically, FTO-mediated demethylation of PRKCB mRNA reduced its recognition by reader proteins that typically promote mRNA decay, thereby prolonging its half-life and enhancing protein translation. Elevated PRKCB promoted IKKβ phosphorylation and subsequent NF-κB activation. Rescue experiments confirmed that FTO regulates alveolar hypercoagulation and fibrinolytic inhibition in ARDS via PRKCB-dependent activation of the NF-κB pathway.
Conclusion: Our study identifies the FTO-PRKCB-NF-κB axis as a novel epitranscriptomic pathway driving alveolar fibrin deposition in ARDS. These findings reveal FTO as a potential therapeutic target for mitigating alveolar hypercoagulation and fibrinolysis inhibition in ARDS.
Related
- mtDNA Activates AIM2-Mediated PANoptosis in Interstitial Macrophages to Promote Immune Checkpoint Inhibitor Pneumonitis
- SIR2-mediated filament assembly activates the NLR-like protein Avs5 for bacterial antiviral defense
- 1111 NIR light mediated mechanical destruction of glioma cells to trigger tumor antigen release and potentiate immunogenic cell death
- MULTIVALENT ACE2 ENGAGEMENT ACTIVATES PIEZO1-SPHINGOMYELINASE SIGNALING IN SARS-COV-2 SPIKE-MEDIATED CELL-CELL FUSION
- EF-P-resolved ribosome stalling and collision trigger Rae1-mediated mRNA decay
BibTeX
@article{chen2026ftomediated,
title = {{FTO-mediated demethylation of PRKCB mRNA activates NF-κB to trigger alveolar fibrin deposition in ARDS}},
author = {Xianjun Chen and Ying Liu and Song Mu and Tingting Chen and Jia Yuan and Chuan Xiao and Qi Dong and Qing Li and Ying Wang and Qimin Chen and Shuwen Li and Wei Li and Feng Shen},
journal = {Frontiers in Immunology},
year = {2026},
month = oct,
doi = {10.3389/fimmu.2026.1960313},
url = {https://www.frontiersin.org/articles/10.3389/fimmu.2026.1960313/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - FTO-mediated demethylation of PRKCB mRNA activates NF-κB to trigger alveolar fibrin deposition in ARDS
AU - Xianjun Chen
AU - Ying Liu
AU - Song Mu
AU - Tingting Chen
AU - Jia Yuan
AU - Chuan Xiao
AU - Qi Dong
AU - Qing Li
AU - Ying Wang
AU - Qimin Chen
AU - Shuwen Li
AU - Wei Li
AU - Feng Shen
PY - 2026
DA - 2026/10/14
JO - Frontiers in Immunology
DO - 10.3389/fimmu.2026.1960313
UR - https://www.frontiersin.org/articles/10.3389/fimmu.2026.1960313/full
AB - Background: Acute Respiratory Distress Syndrome (ARDS) is characterized by alveolar fibrin deposition, driven by dysregulated hypercoagulation and impaired fibrinolysis. Although alveolar epithelial type II (AEC II) cells contribute to this imbalance by overexpressing Tissue Factor (TF) and Plasminogen Activator Inhibitor-1 (PAI-1), the upstream regulatory mechanisms, particularly at the epitranscriptomic level, remain unclear. The potential role of the N6-methyladenosine (m ⁶ A) RNA demethylase FTO in ARDS pathogenesis is unexplored. Methods: In this study, we employed lipopolysaccharide (LPS)-induced rat ARDS models and LPS-stimulated AEC II cells as primary experimental systems to investigate the underlying mechanisms. Multi-omics profiling, combining methylated RNA immunoprecipitation sequencing (MeRIP-seq) and RNA sequencing (RNA-seq), was performed. Gain and loss-of-function studies were conducted using lentiviral vectors both in vitro and in vivo . Mechanistic investigations involved MeRIP-qPCR, mRNA stability assays, co-immunoprecipitation (Co-IP), Western blot, immunofluorescence, and pharmacological modulation of the NF-κB pathway. Results: Lungs from ARDS rats showed decreased global levels and increased FTO expression. Knockdown of FTO alleviated lung injury, reduced pulmonary edema, and suppressed the expression of TF and PAI-1, concomitant with inhibition of NF-κB signaling. Integrated multi-omics analysis identified Protein Kinase C Beta (PRKCB), a serine/threonine kinase known to regulate inflammatory signaling, as a key target of FTO. Mechanistically, FTO-mediated demethylation of PRKCB mRNA reduced its recognition by reader proteins that typically promote mRNA decay, thereby prolonging its half-life and enhancing protein translation. Elevated PRKCB promoted IKKβ phosphorylation and subsequent NF-κB activation. Rescue experiments confirmed that FTO regulates alveolar hypercoagulation and fibrinolytic inhibition in ARDS via PRKCB-dependent activation of the NF-κB pathway. Conclusion: Our study identifies the FTO-PRKCB-NF-κB axis as a novel epitranscriptomic pathway driving alveolar fibrin deposition in ARDS. These findings reveal FTO as a potential therapeutic target for mitigating alveolar hypercoagulation and fibrinolysis inhibition in ARDS.
SN - 1664-3224
ER -